Featured Product

Integrity Biomarker Module

The first biomarker database to classify biomarkers into lifecycle phases and disciplines, the Biomarkers Module of Thomson Reuters Integrity provides a wealth of high-quality, up-to-date information to support your biomarker research at every stage of drug R&D.

Thomson Reuters Integrity

Thomson Reuters Integrity SM provides researchers with reliable, detailed information across multiple disciplines and from the perspective of a scientist – to support successful drug research and development.Integrating biology, chemistry and pharmacology data on more than 320,000 compounds with demonstrated biological activity and almost 140,000 patent family records, Integrity provides a unique knowledge solution designed to empower your discovery and development activities where you need it most – at the bench.